Candel Therapeutics, Inc. · NASDAQ:CADL

Baker Bros. Advisors LP reported a 6.80% stake in Candel Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 14, 2025

Baker Bros. Advisors LP reported a 6.80% stake in Candel Therapeutics, Inc., 2,981,983 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).

Stake
6.80%
Shares
2,981,983
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Baker Bros. Advisors LP6.80%2,981,983
Baker Bros. Advisors (GP) LLC6.80%2,981,983
Julian C. Baker6.80%2,981,983
Felix J. Baker6.80%2,981,983

Source

View original at SEC

Related